EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili
  1. Home
  2. About
  3. Partner programs
  4. Eastern Europe and Central Asia Hepatitis Elimination

Eastern Europe and Central Asia Hepatitis Elimination

green

Eastern Europe and Central Asia Hepatitis Elimination

Virus targets
Hepatitis B
Hepatitis C
Type
Operational research
Technical assistance
Testing and treatment implementation
Setting
National
Other targets
HIV
Syphillis
Tuberculosis
Phase
Planning
Health outcomes
Incidence
Prevalence
WHO region
European Region
Country
Kyrgyzstan
Tajikistan
Uzbekistan
Ukraine
Russian Federation
Key interventions
Blood safety
Community mobilization
Hepatitis B Vaccination
Injection safety and infection control
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Prevention mother-child transmission
Strategic data analysis
Screening and diagnosis
Treatment (direct or referral)
Target population
Adolescents (10 - 19 years of age)
Adults (> 19 years of age)
All ages
Birth cohorts of adults
Blood transfusion recipients
Children (> one year < 10 years of age)
Incarcerated populations (current and former)
Men who have sex with men
Newborn (born in last 30 days)
Occupations with possible exposure
Persons who inject drugs
Pregnant women
Performance target
Blood safety
Care cascade: Evidence of current infection
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Other
Care cascade: Referred for treatment
HBV prevention of mother to child transmission
Hepatitis B vaccination coverage
Injection safety
If you would like to have a program page for your program, please create an account and submit program information here

Health outcomes additional info

Introduction broad hepatitis testing on the level of primary medical help settings with trainings for identification, counseling, and care of infected individuals

Summary and objectives

 

Viral hepatitis populational testing strategy development and implementation for HCV/HBV/HDV infections identification with treatment applications toward elimination in the region of Eastern Europe and Central Asia. Support of key tools development and implementation in the region of EECA: National planning; Data to guide and evaluate program; Health system strengthening; Simplified care models; Strategic information; Political support. Regional introduction of the global coalition to eliminate hepatitis B and hepatitis C by strengthening the capacity of national and sub-national elimination programs through technical assistance, knowledge generation and dissemination and advocacy among partners united in a community of practice.

Last updated

Related

Programs Resources